Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

World Hepatitis Alliance (the Alliance), European Liver Patient Association (ELPA) and Bristol-Myers Squibb Announce Global Expansion of PATH B Programme on World Hepatitis Day to Address the Unmet Need in Resources for People Living with Chronic Hepatitis B


News provided by

Bristol-Myers Squibb

26 Jul, 2012, 09:04 GMT

Share this article

Share toX

Share this article

Share toX

PARIS, July 26, 2012 /PRNewswire/ --

Patients and Professionals Acting Together for Hepatitis B (PATH B),http://www.pathb.com, provides the most comprehensive information and tools available for those at risk and diagnosed with chronic hepatitis B

PATH B expands roll-out to six countries and is now available in theUK,Italy,Portugal,Russia,Spain, Taiwan  and Turkey

The World Hepatitis Alliance (the Alliance), European Liver Patients Association (ELPA) and Bristol-Myers Squibb announced today that the successful PATH B programme has been expanded to support patients living with chronic hepatitis B in a further six countries, with additional countries under consideration.

To view the multimedia assets associated with this release, please click: http://www.multivu.com/players/English/57175-path-b-world-hepatitis-day/

Since the launch of PATH B in the UK in October 2011, the programme has received a large number of requests for it to be available in other countries. This demonstrates that credible, accurate patient resources are highly sought after by not only patients, but also physicians, in a disease area where little or no resources exist.   

PATH B is provided as an educational service by the Alliance and ELPA, and is organised and funded through an unrestricted grant by Bristol-Myers Squibb. The programme is managed by an independent advisory board consisting of patient advocacy group representatives and leading hepatologists from across Europe.

Approximately 350-400 million people worldwide have chronic hepatitis B, an incurable disease for the vast majority of people that can lead to liver cancer.[1,2,3,4]Despite the large incidence, there is a significant lack of credible resources available to patients and caregivers.

"Chronic hepatitis B patients often have limited knowledge of hepatitis B risks, transmission and how to cope with living with the disease," said Tatjana Reic, president, ELPA. "With PATH B now available to patients in multiple countries, we are one step closer in educating people globally about how they can protect themselves from this infection."    

Chronic hepatitis B awareness and education is effective in the prevention and management of the disease, however it is not widely and consistently implemented.[5,6,7] The goal of PATH B is to help those at risk and those already infected with chronic hepatitis B understand the virus' risks and transmission methods and how to best manage living with the disease. The programme also aims to improve the patient-physician dialogue with the hope that this will lead to better outcomes.

"It's time to bring chronic hepatitis B into the spotlight so the nearly 400 million people living with the virus can become fully educated on their condition. And innovative resources like PATH B are a valuable part in helping us get there," said Charles Gore, president, the Alliance.

The new countries include Italy, Portugal, Russia, Spain, Taiwan and Turkey. Additional countries under consideration for PATH B roll-out later in 2012 include Belgium, France, Germany, Greece, The Gulf states and South Korea. 

"PATH B is an example of Bristol-Myers Squibb's commitment to providing programmes that address an unmet need for people living with chronic hepatitis B," said Ron Cooper, president, Bristol-Myers Squibb Europe. "We understand we have an important role to play in addressing these needs by working with patient and professional organisations, physicians and patients."

About PATH B

The PATH B resource was created by an international advisory board of European patient advocacy groups and physicians to address all aspects of chronic viral hepatitis B - from diagnosis to long-term treatment.

The PATH B resource is an interactive PDF that provides credible information on the complete hepatitis B journey through an animated road map illustrating the stages of disease management: before diagnosis, diagnosis, understanding test results, starting treatment and keys to successful long-term disease management. There are also printable fact sheets, wellness tips, and other features such as the patient diary, which can be personalised with medical history, treatment updates and questions for your doctor. The "View Your Progress Tool" allows patients to chart their test results in order to view their treatment progress. 

PATH B Partner Organisations
European Liver Patients Association (ELPA)                                 http://www.elpa-info.org   
World Hepatitis Alliance (Alliance)                                        http://www.worldhepatitisalliance.org
Deutsche Leberhilfe e.V.                                                   http://www.leberhilfe.org
British Liver Trust                                                        http://www.britishlivertrust.org.uk
Associacio Catalana de Malalts d'Hepatitis (ASSCAT)                        http://www.asscat.org
Chinese Healthy Living Centre                                              http://www.cnhlc.org.uk
Associazione EpaC onlus                                                    http://www.epac.it
SOS Hepatites                                                              http://www.soshepatites.org

About Hepatitis B (HBV)

Hepatitis means inflammation of the liver and can include several different types of viral infections that impact the liver's capacity to perform its vital functions.[8] HBV is transmitted through person-to-person contact with infected blood or bodily fluids.[2] The most common mode of transmission varies by geographic region. In Western Europe, a majority of infections are acquired through sexual contact with an infected person, as well as sharing contaminated needles and syringes. However, in Asia and the Middle East, HBV is spread predominantly through mother-to-child and child-to-child transmission.[9] Most individuals suffering from HBV do not show any signs or symptoms, but they do experience a much higher risk of developing cirrhosis and liver cancer.[8] In fact, about 15-25 percent of those affected will develop liver disease caused by HBV.[4] There is no cure for chronic HBV, but there are treatments that can help prevent the development of more severe or life-threatening complications.[3]

For more information on hepatitis B, visit http://www.hepatitisinfo.org.   

About World Hepatitis Day 2012

2012 marks the second annual World Hepatitis Day, as recognised by the World Health Organization (WHO). World Hepatitis Day is sponsored by the WHO and the Alliance. This year's theme of "It's Closer Than You Think" encourages people to understand that hepatitis is everywhere and could affect those close to them, or even themselves. For more information on World Hepatitis Day, visit http://worldhepatitisalliance.org/WorldHepatitisDay.aspx   

About Bristol-Myers Squibb Company

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb has an established expertise in Viral Hepatitis and is proud to support PATH B, a programme addressing a large unmet need for patients living with chronic hepatitis B.

[1] Hepatitis B Foundation. Statistics. Available at http://www.hepb.org/hepb/statistics.htm. Accessed July 2012.

[2] World Hepatitis Alliance. About Viral Hepatitis. Available at http://www.worldhepatitisalliance.org/AboutViralHepatitis.aspx. Accessed July 2012.

[3] Hepatitis B Foundation. Living with Hepatitis B: FAQ. Available at http://www.hepb.org/patients/living_with_hepatitis_b.htm. Accessed July 2012.

[4] Centers for Disease Control and Prevention. Viral Hepatitis Populations. Available at http://www.cdc.gov/hepatitis/Populations/api.htm. Accessed July 2012.

[5] Surjadi M, et al. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Dig Dis Sci 2011; 56:213-219.

[6] Cacoub P, et al. Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study. World J Gastroenterol 2008; 14(40): 6195-6203.

[7] World Hepatitis Alliance. Viral Hepatitis: Global Policy. Available at http://worldhepatitisalliance.org/Libraries/Campaign_Materials/Viral_Hepatitis_Global_Policy.sflb.ashx. Accessed July 2012.

[8] Centers for Disease Control and Prevention. World Hepatitis Day. Available at http://www.cdc.gov/features/viralhepatitis/. Accessed July 2012.

[9] World Health Organization. Hepatitis B Fact Sheet. Available at http://www.who.int/mediacentre/factsheets/fs204/en/index.html. Accessed July 2012.

RHUUK12NP002, Date of preparation July 2012

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.